S&P 500   5,253.88 (+0.10%)
DOW   39,767.51 (+0.02%)
QQQ   444.87 (+0.01%)
AAPL   170.81 (-1.44%)
MSFT   420.69 (-0.18%)
META   489.70 (-0.84%)
GOOGL   150.41 (-0.30%)
AMZN   180.82 (+0.55%)
TSLA   176.92 (-1.62%)
NVDA   908.14 (+0.62%)
NIO   4.63 (-0.86%)
AMD   182.99 (+1.89%)
BABA   72.40 (+1.13%)
T   17.58 (+0.17%)
F   13.19 (+1.00%)
MU   118.42 (-0.60%)
CGC   9.11 (-4.61%)
GE   175.56 (-2.53%)
DIS   122.20 (+1.01%)
AMC   3.74 (-13.82%)
PFE   27.86 (+0.29%)
PYPL   66.94 (+0.56%)
XOM   115.40 (+0.37%)
S&P 500   5,253.88 (+0.10%)
DOW   39,767.51 (+0.02%)
QQQ   444.87 (+0.01%)
AAPL   170.81 (-1.44%)
MSFT   420.69 (-0.18%)
META   489.70 (-0.84%)
GOOGL   150.41 (-0.30%)
AMZN   180.82 (+0.55%)
TSLA   176.92 (-1.62%)
NVDA   908.14 (+0.62%)
NIO   4.63 (-0.86%)
AMD   182.99 (+1.89%)
BABA   72.40 (+1.13%)
T   17.58 (+0.17%)
F   13.19 (+1.00%)
MU   118.42 (-0.60%)
CGC   9.11 (-4.61%)
GE   175.56 (-2.53%)
DIS   122.20 (+1.01%)
AMC   3.74 (-13.82%)
PFE   27.86 (+0.29%)
PYPL   66.94 (+0.56%)
XOM   115.40 (+0.37%)
S&P 500   5,253.88 (+0.10%)
DOW   39,767.51 (+0.02%)
QQQ   444.87 (+0.01%)
AAPL   170.81 (-1.44%)
MSFT   420.69 (-0.18%)
META   489.70 (-0.84%)
GOOGL   150.41 (-0.30%)
AMZN   180.82 (+0.55%)
TSLA   176.92 (-1.62%)
NVDA   908.14 (+0.62%)
NIO   4.63 (-0.86%)
AMD   182.99 (+1.89%)
BABA   72.40 (+1.13%)
T   17.58 (+0.17%)
F   13.19 (+1.00%)
MU   118.42 (-0.60%)
CGC   9.11 (-4.61%)
GE   175.56 (-2.53%)
DIS   122.20 (+1.01%)
AMC   3.74 (-13.82%)
PFE   27.86 (+0.29%)
PYPL   66.94 (+0.56%)
XOM   115.40 (+0.37%)
S&P 500   5,253.88 (+0.10%)
DOW   39,767.51 (+0.02%)
QQQ   444.87 (+0.01%)
AAPL   170.81 (-1.44%)
MSFT   420.69 (-0.18%)
META   489.70 (-0.84%)
GOOGL   150.41 (-0.30%)
AMZN   180.82 (+0.55%)
TSLA   176.92 (-1.62%)
NVDA   908.14 (+0.62%)
NIO   4.63 (-0.86%)
AMD   182.99 (+1.89%)
BABA   72.40 (+1.13%)
T   17.58 (+0.17%)
F   13.19 (+1.00%)
MU   118.42 (-0.60%)
CGC   9.11 (-4.61%)
GE   175.56 (-2.53%)
DIS   122.20 (+1.01%)
AMC   3.74 (-13.82%)
PFE   27.86 (+0.29%)
PYPL   66.94 (+0.56%)
XOM   115.40 (+0.37%)
NYSE:SQZ

SQZ Biotechnologies (SQZ) Stock Price, News & Analysis

$0.05
0.00 (0.00%)
(As of 03/27/2024 ET)
Today's Range
$0.05
$0.05
50-Day Range
$0.03
$0.44
52-Week Range
$0.25
$3.56
Volume
26,000 shs
Average Volume
455,220 shs
Market Capitalization
$1.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SQZ stock logo

About SQZ Biotechnologies Stock (NYSE:SQZ)

SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.

SQZ Stock Price History

SQZ Stock News Headlines

SQZB SQZ Biotechnologies Company
Altcoin FRENZY Alert…
Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days…
SQZ Biotechnologies Co Ordinary Shares SQZB
Lifeline Biotechnologies Inc LLBO
Altcoin FRENZY Alert…
Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days…
Sqz Biotechnologies Co (SQZB)
SQZ Biotechnologies to be delisted from the NYSE
Short Volatility Alert: Sqz Biotechnologies
BTIG Remains a Buy on SQZ Biotechnologies (SQZ)
See More Headlines
Receive SQZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SQZ Biotechnologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/10/2021
Today
3/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Fax
N/A
Employees
53
Year Founded
N/A

Profitability

Net Income
$-79,460,000.00
Net Margins
-369.96%
Pretax Margin
-408.99%

Debt

Sales & Book Value

Annual Sales
$18.16 million
Book Value
$1.94 per share

Miscellaneous

Free Float
24,772,000
Market Cap
$1.37 million
Optionable
Not Optionable
Beta
2.34
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. Howard Bernstein M.D. (Age 66)
    Ph.D., Interim CEO & Director
    Comp: $552.14k
  • Mr. Lawrence J. Knopf Esq. (Age 61)
    Gen. Counsel
    Comp: $512.38k
  • Dr. Marshelle Smith Warren M.D. (Age 60)
    Chief Medical Officer
    Comp: $476.27k
  • Dr. Robert S. Langer Jr. (Age 74)
    Ph.D., Sc.D., SCD, Co-Founder & Member of Scientific Advisory Board
  • Mr. Richard V. Capasso CPA (Age 61)
    Chief Accounting Officer
  • Mr. David First (Age 59)
    Chief People Officer
  • Ipsita Roymoulik Ph.D.
    Sr. VP of CMC & QUALITY

SQZ Stock Analysis - Frequently Asked Questions

How have SQZ shares performed in 2024?

SQZ Biotechnologies' stock was trading at $0.0199 at the start of the year. Since then, SQZ stock has increased by 133.7% and is now trading at $0.0465.
View the best growth stocks for 2024 here
.

How were SQZ Biotechnologies' earnings last quarter?

SQZ Biotechnologies (NYSE:SQZ) posted its quarterly earnings data on Wednesday, November, 10th. The company reported ($8.00) earnings per share (EPS) for the quarter, missing the consensus estimate of ($5.60) by $2.40. The company had revenue of $4.76 million for the quarter, compared to the consensus estimate of $11.64 million. SQZ Biotechnologies had a negative trailing twelve-month return on equity of 119.83% and a negative net margin of 369.96%.

When did SQZ Biotechnologies' stock split?

SQZ Biotechnologies's stock reverse split before market open on Friday, July 7th 2023. The 1-10 reverse split was announced on Friday, July 7th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, July 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

When did SQZ Biotechnologies IPO?

SQZ Biotechnologies (SQZ) raised $75 million in an initial public offering on Friday, October 30th 2020. The company issued 4,400,000 shares at $16.00-$18.00 per share. BofA Securities and Stifel served as the underwriters for the IPO and BTIG was co-manager.

How do I buy shares of SQZ Biotechnologies?

Shares of SQZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:SQZ) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners